3184 Stock Overview
MicroBase Technology Corp. provides drug delivery systems to patients and healthcare professionals in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
MicroBase Technology Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$12.30 |
| 52 Week High | NT$17.30 |
| 52 Week Low | NT$10.90 |
| Beta | 0.10 |
| 1 Month Change | -0.40% |
| 3 Month Change | 2.50% |
| 1 Year Change | -18.27% |
| 3 Year Change | -19.61% |
| 5 Year Change | -34.50% |
| Change since IPO | -5.86% |
Recent News & Updates
Shareholder Returns
| 3184 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -0.8% | -4.3% | -5.7% |
| 1Y | -18.3% | 1.9% | 23.8% |
Return vs Industry: 3184 underperformed the TW Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: 3184 underperformed the TW Market which returned 23.8% over the past year.
Price Volatility
| 3184 volatility | |
|---|---|
| 3184 Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.5% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 3184 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3184's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | n/a | microbasetech.com |
MicroBase Technology Corp. provides drug delivery systems to patients and healthcare professionals in Taiwan. It develops non-silicon-based MEMS by using LIGA technology that could be applied in the manufacture and development of miniaturized devices and micron-scale parts. The company also offers Pocket Air, an inhalation devices for the treatment of respiratory diseases; and PharMatrix, a micro-needles products for women to use at home.
MicroBase Technology Corp. Fundamentals Summary
| 3184 fundamental statistics | |
|---|---|
| Market cap | NT$987.38m |
| Earnings (TTM) | NT$38.11m |
| Revenue (TTM) | NT$194.75m |
25.9x
P/E Ratio5.1x
P/S RatioIs 3184 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3184 income statement (TTM) | |
|---|---|
| Revenue | NT$194.75m |
| Cost of Revenue | NT$100.97m |
| Gross Profit | NT$93.78m |
| Other Expenses | NT$55.68m |
| Earnings | NT$38.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.47 |
| Gross Margin | 48.15% |
| Net Profit Margin | 19.57% |
| Debt/Equity Ratio | 3.4% |
How did 3184 perform over the long term?
See historical performance and comparison